Drug Side Effects
Search
CUTANEOUS T-CELL LYMPHOMA STAGE I
CUTANEOUS T-CELL LYMPHOMA STAGE I
was reported 36 times
These drug classes are most commonly taken by patients reporting CUTANEOUS T-CELL LYMPHOMA STAGE I:
#
Drug
Count
0
Interleukin-4 Receptor alpha Antagonist [EPC]
12
1
Folate Analog Metabolic Inhibitor [EPC]
9
2
Glycopeptide Antibacterial [EPC]
9
3
Interferon alpha [EPC]
9
4
Leukocyte Growth Factor [EPC]
9
5
Loop Diuretic [EPC]
9
6
Penem Antibacterial [EPC]
9
7
Retinoid [EPC]
9
8
Xanthine Oxidase Inhibitor [EPC]
9
9
Calcineurin Inhibitor Immunosuppressant [EPC]
6
10
Opioid Agonist [EPC]
6
11
Tumor Necrosis Factor Blocker [EPC]
6
12
Corticosteroid [EPC]
4
13
Interleukin-12 Antagonist [EPC]
3
14
Interleukin-23 Antagonist [EPC]
3
15
Antimetabolite [EPC]
2
16
CD20-directed Cytolytic Antibody [EPC]
1
17
CD30-directed Immunoconjugate [EPC]
1
18
Interleukin-17A Antagonist [EPC]
1
19
Nonsteroidal Anti-inflammatory Drug [EPC]
1
20
Platelet Aggregation Inhibitor [EPC]
1
21
Sphingosine 1-phosphate Receptor Modulator [EPC]
1